-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
224 ，《》！
，，《》。
，20149，《》（《》），，，、《》。
《》，。
，201910，20《（）》，《》，“”，。
，
“”
《》，，《“”》、。、、，“”。
、
《》，、、，、、，、。
，，《》，、、。
、
、
《》，，、、，，；，，。
，，、、、。
1，
，、、、。
、、，1，、、、、、。
，
、、、，，。
、、、、、，，。
201910，20《（）》（《》），、。《》，“”，《》，、。
：
：，，，，《》、《》、《》、《》、《》、《》、《（）》，。
：，、、、、、、、、、、、、。
：（），，、，，，、，，。
Article 4: All institutions that carry out medical scientific research work should abide by these norms, carry out normalized scientific research integrity education and training, strengthen system construction, and strive to create an institutional environment that is conducive to fostering scientific research integrity.
Chapter II The Code of Integrity Behavior of Medical Researchers
Article 5: Medical researchers must follow the scientific research ethics guidelines in scientific research activities, actively apply for ethical review, accept ethical supervision, and effectively protect the legitimate rights and interests of subjects.
Article 6: When conducting scientific research and academic activities such as project application, medical researchers must ensure that the provided academic qualifications, work experience, published papers, published monographs, award certificates, cited papers, patent certificates and other relevant information are true and accurate.
Article 7: Medical researchers must be objective, comprehensive and accurate when collecting scientific research samples, data and materials; they must establish national security and confidentiality awareness, and strictly abide by relevant laws for biosecurity, state secrets, work secrets and personal privacy.
pharmnet.
com.
cn/" target="_blank">Regulations .
pharmnet.
com.
cn/" target="_blank">Regulations .
Article 8: During research, medical researchers shall honestly record the research process and results, truthfully and standardizedly write medical records, including adverse reactions and events, and report serious adverse reactions and events in a timely manner in accordance with relevant regulations.
Article 9: In research involving infectious diseases, newly emerging infectious diseases, diseases of unknown cause, and modification of known pathogens, medical researchers must establish awareness of public health and laboratory biosafety, and conduct research in biosafety laboratories of the corresponding level The collection, transportation, and treatment of pathogens should consciously comply with the requirements of relevant laws and regulations, report infectious diseases, new or suspected cases of infection in accordance with laws and regulations, retain relevant vouchers, and accept the supervision and management of relevant departments.
Article 10: After the completion of the research, medical scientific research personnel shall follow the corresponding biosafety and scientific research management regulations for the storage, sharing and destruction of human or animal samples, toxic substances, data or materials.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
Article 11: In animal experiments, medical researchers should consciously abide by the "Regulations on the Management of Laboratory Animals", strictly select qualified animals that meet the requirements for experiments, and use, protect and treat animals scientifically and rationally.
Article 12 When conducting academic exchanges and reviewing other people's academic papers or project declarations, medical researchers shall respect and protect the intellectual property rights of others and abide by the rules of scientific and technological confidentiality.
Article 13 When citing research opinions, data, images, results, or other research materials published by others, medical researchers must ensure that they are true and accurate and honestly indicate the source, and citation notes and reference labeling must comply with academic standards.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
Article 14 In the process of publishing papers or academic works, medical researchers must abide by the "Five Prohibitions for Publishing Academic Papers" and the relevant regulations on academic paper submission and publication.
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
Article 15 As tutors or scientific research project leaders, medical researchers must give full play to their precepts and deeds.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
Article 16 Medical scientific research personnel shall carefully review the results to be published to avoid errors and mistakes.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Article 17 Medical scientific research personnel must provide true and complete materials, including published papers, literature citations, third-party evaluation certificates, etc.
, during project acceptance, achievement registration, and application for rewards.
, during project acceptance, achievement registration, and application for rewards.
Article 18 When participating in scientific and technological review and other activities as review experts, consultants, evaluators, and fund auditors, medical scientific researchers must be loyal to their duties, strictly abide by the requirements of scientific research integrity, confidentiality, avoidance regulations, and professional ethics, and follow relevant regulations and procedures.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
Article 19 When conducting scientific research cooperation with others, medical researchers shall earnestly fulfill their fiduciary obligations and contractual agreements.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
Article 20 Medical scientific research personnel shall strictly abide by the regulations on the management of scientific research funds, and shall not make false reports, false claims, or misappropriate scientific research funds.
Article 21 Medical researchers should uphold the spirit of science and adhere to social responsibilities in the promotion of results and popular science, avoid false statements and news hype, do not artificially exaggerate the research foundation and academic value, and must not disseminate unproven scientifically to the public Phenomenon and opinions.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
When medical scientific researchers release research results related to the epidemic, they should firmly establish awareness of public health, scientific research integrity and ethics, and strictly abide by relevant laws and regulations and relevant epidemic prevention and control management requirements.
Article 22 The academic part-time jobs of medical researchers shall be related to their own research majors, and part-time jobs with no substantive work content and nicknames shall be eliminated.
Chapter III Integrity Standards of Medical Research Institutions
Article 23 Medical scientific research institutions shall formulate and improve their own scientific research integrity case investigation and handling methods in accordance with the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)", clarify specific requirements such as investigation procedures, handling rules, and handling measures, and carefully organize relevant Investigation and processing.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
Article 24: Medical scientific research institutions shall take the initiative to investigate and deal with the scientific research misconduct of their institutions, and at the same time shall strictly protect the personal information of informants.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
Article 25 A medical scientific research institution shall, through its charter or academic committee charter, clearly stipulate the tasks, duties and powers of scientific research integrity.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
Article 26 Medical scientific research institutions shall strengthen the management of scientific research results, and establish a system of achievement management such as the credit commitment system for academic paper publication, the traceability system of scientific research process, the inspection and reporting system of scientific research results, and so on.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Article 27: Medical scientific research institutions shall strengthen the signature management of scientific research papers and results published, and strictly investigate the responsibilities of non-substantial contributions in accordance with laws and regulations; establish and improve various systems such as scientific research activity records and scientific research archive preservation, and clarify responsibilities The main body, improve the internal supervision and restraint mechanism; it is necessary to properly manage the original data, biological information, pictures, records, etc.
related to the medical research of the institution for verification.
related to the medical research of the institution for verification.
Article 28 The medical research institution shall strengthen the management of the papers published by the medical scientific research personnel in the institution, and shall not allow the number of papers published, impact factors, etc.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
Article 29 Medical scientific research institutions shall incorporate scientific research integrity education into the vocational training and education system for medical researchers, continuously improve the content and methods of education, and create a good atmosphere and culture that advocates scientific research integrity.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Article 30 When organizing applications for scientific research projects and recommending applications for scientific and technological achievements awards, medical scientific research institutions shall instruct applicants to observe scientific research integrity, and may sign scientific research integrity commitments and publicize relevant information.
Article 31 Medical scientific research institutions shall promptly report the handling decisions to the scientific research integrity authorities for verified untrustworthy conducts in scientific research, and serve as an important reference for their promotion, title evaluation, achievement awards, review and commendation, etc.
Article 32 Medical scientific research institutions shall review research, papers, and results in areas such as infectious diseases and biosafety, evaluate their potential impact on social and public health safety, and assume corresponding responsibilities.
Article 33: The person in charge of medical scientific research institutions, academic leaders, and scientific research management personnel shall set an example, strictly abide by the relevant scientific research integrity management regulations, and shall not use their positions to infringe on the scientific research results of others or seek improper interests.
Chapter IV Supplementary Provisions
Article 34 This specification shall come into force on the date of promulgation.
National Health Health Committee General Office
February 19, 2021
Medical News, February 24, after seven years, the "Medical Research Integrity and Related Code of Conduct" ushered in revision!
Recently, according to the news from the Department of Science, Technology and Education of the National Health Commission, the official website of the National Health Commission officially issued the "Notice on Issuing the Integrity of Medical Research and Related Codes of Conduct.
"
"
It is reported that this was based on the "Code of Integrity in Medical Research and Related Conduct" (hereinafter referred to as the "Code") jointly issued by the former National Health and Family Planning Commission and the State Administration of Traditional Chinese Medicine (hereinafter referred to as the "Code") in September 2014.
In the field of medical scientific research, the establishment of scientific research integrity was further strengthened.
The National Health Commission, together with the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine, jointly revised the "Specifications.
"
In the field of medical scientific research, the establishment of scientific research integrity was further strengthened.
The National Health Commission, together with the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine, jointly revised the "Specifications.
"
The "Specifications" apply to all personnel engaged in medical scientific research activities and all institutions that carry out medical scientific research, and are not limited to medical and health institutions and medical scientific research institutions directly under the administrative departments of health at all levels and their scientific researchers.
It is reported that in October 2019, the Ministry of Science and Technology, in conjunction with the National Health Commission and other 20 departments, formulated the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)".
The revised "Specifications" further clarified the standards for medical scientific research integrity and related behaviors.
With the boundary of "right and wrong", the two documents will play a synergistic role.
The revised "Specifications" further clarified the standards for medical scientific research integrity and related behaviors.
With the boundary of "right and wrong", the two documents will play a synergistic role.
Medical researchers publish papers,
Those with no substantive contributors shall not be "named"
The "Specifications" stipulate that in the process of publishing papers or academic works, medical researchers must abide by the "Five Prohibitions for Publishing Academic Papers" and the relevant regulations on academic paper submission and publication.
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
Mentors or research project leaders must not embezzle students,
Legitimate interests of team members
The "Specifications" clarify that supervisors and scientific research project leaders must review manuscripts and scientific research results that need to be signed using their own mailboxes, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not encroach upon students, The legitimate rights and interests of team members.
At the same time, in light of the current new challenges facing the integrity of medical scientific research, the "Specifications" clearly stated that the supervisors and project leaders who agreed to sign should bear the same responsibility for the management and guidance of scientific research misconduct.
It is not allowed to publish the number of papers,
Impact factors, etc.
and personnel rewards, bonuses,
and personnel rewards, bonuses,
Clinician assessment and other links
The "Specifications" requires that medical research institutions should strengthen the management of papers published by medical researchers in their institutions, and it is not allowed to link the number of papers published, impact factors, etc.
with personnel rewards, bonuses, and clinical work assessments.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
with personnel rewards, bonuses, and clinical work assessments.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
The medical scientific research institution shall promptly report the handling decision to the scientific research integrity authority for the verified untrustworthy conduct of scientific research, and use it as an important reference for its promotion, title evaluation, achievement awards, review and recognition, etc.
Within 1 month after the publication of relevant papers and other scientific research results ,
To submit the original information to the institution
After the completion of the research, medical scientific research personnel shall follow the corresponding biosafety and scientific research management regulations for the storage, sharing and destruction of human or animal samples, toxic substances, data or materials.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
When citing other undisclosed design ideas, etc.
,
,
Public thanks or explanation
At the same time, when citing research opinions, data, images, results, or other research materials published by others, medical researchers must ensure that they are true and accurate and honestly indicate the source, and citation notes and reference labeling must comply with academic standards.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
As early as October 2019, the Ministry of Science and Technology, in conjunction with the National Health Commission and other 20 departments, formulated the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)" (hereinafter referred to as the "Investigation and Handling Rules"), responsibilities and procedures for the investigation of scientific research integrity cases, etc.
Clearly stipulated.
The revised "Specifications" further clarify the standards of medical scientific research integrity and related behaviors, define the boundaries of "right and wrong", and will work in concert with the "Investigation and Handling Rules", continuous improvement, and continuous creation of a clean and upright attitude.
Good medical research atmosphere.
Clearly stipulated.
The revised "Specifications" further clarify the standards of medical scientific research integrity and related behaviors, define the boundaries of "right and wrong", and will work in concert with the "Investigation and Handling Rules", continuous improvement, and continuous creation of a clean and upright attitude.
Good medical research atmosphere.
Attachment: Medical research integrity and related codes of conduct
Chapter I General Provisions
Article 1: In order to practice the core socialist values, strengthen the integrity of medical scientific research, improve the professional ethics of medical researchers, and prevent scientific research misconduct, in accordance with the "Science and Technology Progress Law of the People's Republic of China" and "The Copyright Law of the People's Republic of China" , "Regulations of the People's Republic of China on the Management of Human Genetic Resources", "Measures for the Ethical Review of Biomedical Research Involving People", "Several Opinions on Further Strengthening the Construction of Scientific Research Credit", "Opinions on Further Promoting the Spirit of Scientists and Strengthening the Construction of Work Style and Study Style" , "Scientific Research Integrity Case Investigation and Handling Rules (Trial)" and other relevant regulations, formulate this specification
Article 2: The medical scientific research activities referred to in this specification refer to the conduct of medical scientific research institutions and their personnel in the fields of basic medicine, clinical medicine, preventive medicine and public health, pharmacy, traditional Chinese medicine and traditional Chinese medicine.
It involves behavioral activities in the links of scientific research project application, pre-experimental research, research implementation, result report, project inspection, execution process management, summary publication of results, evaluation and review, and acceptance.
It involves behavioral activities in the links of scientific research project application, pre-experimental research, research implementation, result report, project inspection, execution process management, summary publication of results, evaluation and review, and acceptance.
Article 3: All personnel engaged in medical scientific research activities (hereinafter referred to as medical scientific researchers) shall consciously abide by this code, vigorously promote the spirit of scientists, pursue truth, seek truth from facts, follow scientific research ethics and academic norms, respect colleagues and their labor, and prevent quick success , Impetuous and exaggerated, adhere to the bottom line of integrity, and consciously resist scientific research misconduct.
Article 4: All institutions that carry out medical scientific research work should abide by these norms, carry out normalized scientific research integrity education and training, strengthen system construction, and strive to create an institutional environment that is conducive to fostering scientific research integrity.
Chapter II The Code of Integrity Behavior of Medical Researchers
Article 5: Medical researchers must follow the scientific research ethics guidelines in scientific research activities, actively apply for ethical review, accept ethical supervision, and effectively protect the legitimate rights and interests of subjects.
Article 6: When conducting scientific research and academic activities such as project application, medical researchers must ensure that the provided academic qualifications, work experience, published papers, published monographs, award certificates, cited papers, patent certificates and other relevant information are true and accurate.
Article 7: Medical researchers must be objective, comprehensive and accurate when collecting scientific research samples, data and materials; they must establish national security and confidentiality awareness, and strictly abide by relevant laws for biosecurity, state secrets, work secrets and personal privacy.
pharmnet.
com.
cn/" target="_blank">Regulations .
pharmnet.
com.
cn/" target="_blank">Regulations .
Article 8: During research, medical researchers shall honestly record the research process and results, truthfully and standardizedly write medical records, including adverse reactions and events, and report serious adverse reactions and events in a timely manner in accordance with relevant regulations.
Article 9: In research involving infectious diseases, newly emerging infectious diseases, diseases of unknown cause, and modification of known pathogens, medical researchers must establish awareness of public health and laboratory biosafety, and conduct research in biosafety laboratories of the corresponding level The collection, transportation, and treatment of pathogens should consciously comply with the requirements of relevant laws and regulations, report infectious diseases, new or suspected cases of infection in accordance with laws and regulations, retain relevant vouchers, and accept the supervision and management of relevant departments.
Article 10: After the completion of the research, medical scientific research personnel shall follow the corresponding biosafety and scientific research management regulations for the storage, sharing and destruction of human or animal samples, toxic substances, data or materials.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
Article 11: In animal experiments, medical researchers should consciously abide by the "Regulations on the Management of Laboratory Animals", strictly select qualified animals that meet the requirements for experiments, and use, protect and treat animals scientifically and rationally.
Article 12 When conducting academic exchanges and reviewing other people's academic papers or project declarations, medical researchers shall respect and protect the intellectual property rights of others and abide by the rules of scientific and technological confidentiality.
Article 13 When citing research opinions, data, images, results, or other research materials published by others, medical researchers must ensure that they are true and accurate and honestly indicate the source, and citation notes and reference labeling must comply with academic standards.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
Article 14 In the process of publishing papers or academic works, medical researchers must abide by the "Five Prohibitions for Publishing Academic Papers" and the relevant regulations on academic paper submission and publication.
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
Article 15 As tutors or scientific research project leaders, medical researchers must give full play to their precepts and deeds.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
Article 16 Medical scientific research personnel shall carefully review the results to be published to avoid errors and mistakes.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Article 17 Medical scientific research personnel must provide true and complete materials, including published papers, literature citations, third-party evaluation certificates, etc.
, during project acceptance, achievement registration, and application for rewards.
, during project acceptance, achievement registration, and application for rewards.
Article 18 When participating in scientific and technological review and other activities as review experts, consultants, evaluators, and fund auditors, medical scientific researchers must be loyal to their duties, strictly abide by the requirements of scientific research integrity, confidentiality, avoidance regulations, and professional ethics, and follow relevant regulations and procedures.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
Article 19 When conducting scientific research cooperation with others, medical researchers shall earnestly fulfill their fiduciary obligations and contractual agreements.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
Article 20 Medical scientific research personnel shall strictly abide by the regulations on the management of scientific research funds, and shall not make false reports, false claims, or misappropriate scientific research funds.
Article 21 Medical researchers should uphold the spirit of science and adhere to social responsibilities in the promotion of results and popular science, avoid false statements and news hype, do not artificially exaggerate the research foundation and academic value, and must not disseminate unproven scientifically to the public Phenomenon and opinions.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
When medical scientific researchers release research results related to the epidemic, they should firmly establish awareness of public health, scientific research integrity and ethics, and strictly abide by relevant laws and regulations and relevant epidemic prevention and control management requirements.
Article 22 The academic part-time jobs of medical researchers shall be related to their own research majors, and part-time jobs with no substantive work content and nicknames shall be eliminated.
Chapter III Integrity Standards of Medical Research Institutions
Article 23 Medical scientific research institutions shall formulate and improve their own scientific research integrity case investigation and handling methods in accordance with the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)", clarify specific requirements such as investigation procedures, handling rules, and handling measures, and carefully organize relevant Investigation and processing.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
Article 24: Medical scientific research institutions shall take the initiative to investigate and deal with the scientific research misconduct of their institutions, and at the same time shall strictly protect the personal information of informants.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
Article 25 A medical scientific research institution shall, through its charter or academic committee charter, clearly stipulate the tasks, duties and powers of scientific research integrity.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
Article 26 Medical scientific research institutions shall strengthen the management of scientific research results, and establish a system of achievement management such as the credit commitment system for academic paper publication, the traceability system of scientific research process, the inspection and reporting system of scientific research results, and so on.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Article 27: Medical scientific research institutions shall strengthen the signature management of scientific research papers and results published, and strictly investigate the responsibilities of non-substantial contributions in accordance with laws and regulations; establish and improve various systems such as scientific research activity records and scientific research archive preservation, and clarify responsibilities The main body, improve the internal supervision and restraint mechanism; it is necessary to properly manage the original data, biological information, pictures, records, etc.
related to the medical research of the institution for verification.
related to the medical research of the institution for verification.
Article 28 The medical research institution shall strengthen the management of the papers published by the medical scientific research personnel in the institution, and shall not allow the number of papers published, impact factors, etc.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
Article 29 Medical scientific research institutions shall incorporate scientific research integrity education into the vocational training and education system for medical researchers, continuously improve the content and methods of education, and create a good atmosphere and culture that advocates scientific research integrity.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Article 30 When organizing applications for scientific research projects and recommending applications for scientific and technological achievements awards, medical scientific research institutions shall instruct applicants to observe scientific research integrity, and may sign scientific research integrity commitments and publicize relevant information.
Article 31 Medical scientific research institutions shall promptly report the handling decisions to the scientific research integrity authorities for verified untrustworthy conducts in scientific research, and serve as an important reference for their promotion, title evaluation, achievement awards, review and commendation, etc.
Article 32 Medical scientific research institutions shall review research, papers, and results in areas such as infectious diseases and biosafety, evaluate their potential impact on social and public health safety, and assume corresponding responsibilities.
Article 33: The person in charge of medical scientific research institutions, academic leaders, and scientific research management personnel shall set an example, strictly abide by the relevant scientific research integrity management regulations, and shall not use their positions to infringe on the scientific research results of others or seek improper interests.
Chapter IV Supplementary Provisions
Article 34 This specification shall come into force on the date of promulgation.
National Health Health Committee General Office
February 19, 2021
Medical News, February 24, after seven years, the "Medical Research Integrity and Related Code of Conduct" ushered in revision!
Recently, according to the news from the Department of Science, Technology and Education of the National Health Commission, the official website of the National Health Commission officially issued the "Notice on Issuing the Integrity of Medical Research and Related Codes of Conduct.
"
"
It is reported that this was based on the "Code of Integrity in Medical Research and Related Conduct" (hereinafter referred to as the "Code") jointly issued by the former National Health and Family Planning Commission and the State Administration of Traditional Chinese Medicine (hereinafter referred to as the "Code") in September 2014.
In the field of medical scientific research, the establishment of scientific research integrity was further strengthened.
The National Health Commission, together with the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine, jointly revised the "Specifications.
"
Medicine Medicine Medicine Chinese Medicine Chinese Medicine Chinese MedicineIn the field of medical scientific research, the establishment of scientific research integrity was further strengthened.
The National Health Commission, together with the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine, jointly revised the "Specifications.
"
The "Specifications" apply to all personnel engaged in medical scientific research activities and all institutions that carry out medical scientific research, and are not limited to medical and health institutions and medical scientific research institutions directly under the administrative departments of health at all levels and their scientific researchers.
It is reported that in October 2019, the Ministry of Science and Technology, in conjunction with the National Health Commission and other 20 departments, formulated the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)".
The revised "Specifications" further clarified the standards for medical scientific research integrity and related behaviors.
With the boundary of "right and wrong", the two documents will play a synergistic role.
The revised "Specifications" further clarified the standards for medical scientific research integrity and related behaviors.
With the boundary of "right and wrong", the two documents will play a synergistic role.
Medical researchers publish papers,
Medical researchers publish papers, Those with no substantive contributors shall not be "named"
Those with no substantive contributors shall not be "named" The "Specifications" stipulate that in the process of publishing papers or academic works, medical researchers must abide by the "Five Prohibitions for Publishing Academic Papers" and the relevant regulations on academic paper submission and publication.
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
Mentors or research project leaders must not embezzle students,
Mentors or research project leaders must not embezzle students, Legitimate interests of team members
Legitimate interests of team members The "Specifications" clarify that supervisors and scientific research project leaders must review manuscripts and scientific research results that need to be signed using their own mailboxes, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not encroach upon students, The legitimate rights and interests of team members.
At the same time, in light of the current new challenges facing the integrity of medical scientific research, the "Specifications" clearly stated that the supervisors and project leaders who agreed to sign should bear the same responsibility for the management and guidance of scientific research misconduct.
It is not allowed to publish the number of papers,
It is not allowed to publish the number of papers, Impact factors, etc.
and personnel rewards, bonuses,
Impact factors, etc. and personnel rewards, bonuses,
and personnel rewards, bonuses,
Clinician assessment and other links
Clinician assessment and other links The "Specifications" requires that medical research institutions should strengthen the management of papers published by medical researchers in their institutions, and it is not allowed to link the number of papers published, impact factors, etc.
with personnel rewards, bonuses, and clinical work assessments.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
with personnel rewards, bonuses, and clinical work assessments.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
The medical scientific research institution shall promptly report the handling decision to the scientific research integrity authority for the verified untrustworthy conduct of scientific research, and use it as an important reference for its promotion, title evaluation, achievement awards, review and recognition, etc.
Within 1 month after the publication of relevant papers and other scientific research results ,
Within 1 month after the publication of relevant papers and other scientific research results , To submit the original information to the institution
To submit the original information to the institution After the completion of the research, medical scientific research personnel shall follow the corresponding biosafety and scientific research management regulations for the storage, sharing and destruction of human or animal samples, toxic substances, data or materials.
The relevant materials and data of the paper should be complete, complete, true and accurate.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
Within 1 month after the publication of the relevant papers and other scientific research results, the original data and materials involved in the original pictures, experimental records, experimental data, biological information, and records should be submitted.
The institution where it belongs is managed uniformly and kept for future reference.
When citing other undisclosed design ideas, etc.
,
When citing other undisclosed design ideas, etc. ,
,
Public thanks or explanation
Public thanks or explanation At the same time, when citing research opinions, data, images, results, or other research materials published by others, medical researchers must ensure that they are true and accurate and honestly indicate the source, and citation notes and reference labeling must comply with academic standards.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
201910，20《（）》（《》），、。《》，“”，《》，、。
：
： ：，，，，《》、《》、《》、《》、《》、《》、《（）》，。
：，、、、、、、、、、、、、。
：（），，、，，，、，，。
：，，，。
：，，，。
：，、、、、、、、。
：、、、；，、、pharmnet.
com.
cn/" target="_blank">。
pharmnet. com.
cn/" target="_blank">。
com.
cn/" target="_blank">pharmnet.
com.
cn/" target="_blank">
：，，、，，。
：、、，，，、，、，，。
：，、、、。、、，1，、、、、、。
：，《》，，、。
、，，。
Article 13 When citing research opinions, data, images, results, or other research materials published by others, medical researchers must ensure that they are true and accurate and honestly indicate the source, and citation notes and reference labeling must comply with academic standards.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
When using design ideas, academic opinions, experimental data, biological information, graphs, research results, and conclusions that have not been published publicly by others, the written informed consent of the person shall be obtained, and public acknowledgments or explanations shall be obtained at the same time.
Article 14 In the process of publishing papers or academic works, medical researchers must abide by the "Five Prohibitions for Publishing Academic Papers" and the relevant regulations on academic paper submission and publication.
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
The signatures of papers, works, patents and other achievements shall be signed and ranked according to the size of their contributions to scientific research results, and those without substantial academic contributions shall not be "named".
Article 15 As tutors or scientific research project leaders, medical researchers must give full play to their precepts and deeds.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
They must be highly responsible when instructing students or leading research team members to carry out scientific research activities.
They must strictly control and strengthen the supervision of project (project) members and students.
Scientific research integrity management.
Mentors and scientific research project leaders must review the manuscripts submitted using their own mailboxes and scientific research results that need to be signed, and be responsible for the signatures of scientific research results, the authenticity of research data, and the repeatability of experiments, and shall not infringe upon the legitimate rights and interests of students and team members .
If students or team members engage in misconduct in scientific research activities, they agree that the mentor and the person in charge of the scientific research project who participated in the signature shall not only assume the corresponding leadership and guidance responsibilities, but also bear the same responsibility as the person directly responsible for the scientific misconduct.
Article 16 Medical scientific research personnel shall carefully review the results to be published to avoid errors and mistakes.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Errors and mistakes in published research results shall be publicly acknowledged and corrected or withdrawn in an appropriate manner.
Article 17 Medical scientific research personnel must provide true and complete materials, including published papers, literature citations, third-party evaluation certificates, etc.
, during project acceptance, achievement registration, and application for rewards.
, during project acceptance, achievement registration, and application for rewards.
Article 18 When participating in scientific and technological review and other activities as review experts, consultants, evaluators, and fund auditors, medical scientific researchers must be loyal to their duties, strictly abide by the requirements of scientific research integrity, confidentiality, avoidance regulations, and professional ethics, and follow relevant regulations and procedures.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
And methods, seeking truth from facts, working independently, objectively and impartially, providing responsible and high-quality consulting and reviewing opinions, not seeking personal gain in violation of regulations, not participating in consulting and reviewing activities in areas that you are not familiar with, and not knowing the situation and the content of the opinions and suggestions Sign your name.
Article 19 When conducting scientific research cooperation with others, medical researchers shall earnestly fulfill their fiduciary obligations and contractual agreements.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
When publishing papers, publishing works, applying for patents and awards, etc.
, they shall reasonably sign their names based on the contributions of the parties to the cooperation.
Article 20 Medical scientific research personnel shall strictly abide by the regulations on the management of scientific research funds, and shall not make false reports, false claims, or misappropriate scientific research funds.
Article 21 Medical researchers should uphold the spirit of science and adhere to social responsibilities in the promotion of results and popular science, avoid false statements and news hype, do not artificially exaggerate the research foundation and academic value, and must not disseminate unproven scientifically to the public Phenomenon and opinions.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
Medical researchers who announce breakthrough scientific and technological achievements and major scientific research progress shall be approved by the institution where they are located.
The promotion and transformation of scientific and technological achievements shall not deliberately exaggerate the technological value and economic and social benefits, shall not conceal technological risks, and shall be able to withstand peer review, user use, and market recognition.
When medical scientific researchers release research results related to the epidemic, they should firmly establish awareness of public health, scientific research integrity and ethics, and strictly abide by relevant laws and regulations and relevant epidemic prevention and control management requirements.
Article 22 The academic part-time jobs of medical researchers shall be related to their own research majors, and part-time jobs with no substantive work content and nicknames shall be eliminated.
Chapter III Integrity Standards of Medical Research Institutions
Chapter III Integrity Standards of Medical Research Institutions Article 23 Medical scientific research institutions shall formulate and improve their own scientific research integrity case investigation and handling methods in accordance with the "Rules for the Investigation and Handling of Scientific Research Integrity Cases (Trial)", clarify specific requirements such as investigation procedures, handling rules, and handling measures, and carefully organize relevant Investigation and processing.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
The relevant departments shall actively cooperate and assist in investigating the institution's scientific research misconduct.
Article 24: Medical scientific research institutions shall take the initiative to investigate and deal with the scientific research misconduct of their institutions, and at the same time shall strictly protect the personal information of informants.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
The investigation shall include administrative investigation and academic review, and guarantee the legal rights of the relevant responsible party to appeal and other legal rights.
The investigation results and handling opinions shall be confirmed face-to-face with the persons involved and announced.
Article 25 A medical scientific research institution shall, through its charter or academic committee charter, clearly stipulate the tasks, duties and powers of scientific research integrity.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
The academic committee must earnestly perform its responsibilities for the construction of scientific research integrity, and earnestly play its role in deliberation, evaluation, acceptance, investigation, supervision, and consultation.
The academic committee shall regularly organize or entrust academic organizations and third-party institutions to check the important academic papers and other scientific research achievements of the medical researchers of the institution.
Article 26 Medical scientific research institutions shall strengthen the management of scientific research results, and establish a system of achievement management such as the credit commitment system for academic paper publication, the traceability system of scientific research process, the inspection and reporting system of scientific research results, and so on.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Where there is scientific research misconduct in academic papers and other scientific research results, the corresponding responsible persons shall be severely dealt with in accordance with laws and regulations and required to take measures such as withdrawing the papers to eliminate adverse effects.
Article 27: Medical scientific research institutions shall strengthen the signature management of scientific research papers and results published, and strictly investigate the responsibilities of non-substantial contributions in accordance with laws and regulations; establish and improve various systems such as scientific research activity records and scientific research archive preservation, and clarify responsibilities The main body, improve the internal supervision and restraint mechanism; it is necessary to properly manage the original data, biological information, pictures, records, etc.
related to the medical research of the institution for verification.
related to the medical research of the institution for verification.
Article 28 The medical research institution shall strengthen the management of the papers published by the medical scientific research personnel in the institution, and shall not allow the number of papers published, impact factors, etc.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
to be linked with personnel rewards and bonuses, clinical work assessments, etc.
, and for journals on the early warning list of academic journals.
Medical researchers who publish papers must be alerted in time; papers published in journals on the blacklist of academic journals shall not be recognized in various reviews and evaluations, and expenses related to paper publication shall not be reimbursed.
Article 29 Medical scientific research institutions shall incorporate scientific research integrity education into the vocational training and education system for medical researchers, continuously improve the content and methods of education, and create a good atmosphere and culture that advocates scientific research integrity.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Carry out scientific research integrity education at important nodes such as enrollment, job title promotion, participation in science and technology plan projects, major national projects, and talent projects.
For personnel with tendentious and incipient problems in scientific research integrity, the institution where they belong shall promptly conduct scientific research integrity conversation reminders and strengthen education.
Article 30 When organizing applications for scientific research projects and recommending applications for scientific and technological achievements awards, medical scientific research institutions shall instruct applicants to observe scientific research integrity, and may sign scientific research integrity commitments and publicize relevant information.
Article 31 Medical scientific research institutions shall promptly report the handling decisions to the scientific research integrity authorities for verified untrustworthy conducts in scientific research, and serve as an important reference for their promotion, title evaluation, achievement awards, review and commendation, etc.
Article 32 Medical scientific research institutions shall review research, papers, and results in areas such as infectious diseases and biosafety, evaluate their potential impact on social and public health safety, and assume corresponding responsibilities.
Article 33: The person in charge of medical scientific research institutions, academic leaders, and scientific research management personnel shall set an example, strictly abide by the relevant scientific research integrity management regulations, and shall not use their positions to infringe on the scientific research results of others or seek improper interests.
Chapter IV Supplementary Provisions
Chapter IV Supplementary Provisions Article 34 This specification shall come into force on the date of promulgation.
National Health Health Committee General Office
Healthy, healthy, healthy February 19, 2021
